GENE ONLINE|News &
Opinion
Blog

2021-11-21| Special

The Era of Enzymatic DNA Synthesis: How Can DNA Printing Be Useful for Research?

by Ameya Paleja
Share To
If you were involved in molecular biology research at the turn of the millennium, you would remember how painful it was to determine the effect of changes in DNA sequence in your gene of interest. Not only did you have to carry out lengthy assays, but you also needed to first make those changes happen yourself.

DNA printing is the branch of synthetic biology that deals with manufacturing DNA molecules on a large scale. In the past, manufacturing has relied on bacterial fermentation systems that are long drawn out processes and even require the use of antibiotic resistance genes to select the right bacteria in the mix. The method generates a significant amount of waste and is also time-intensive since there are a series of steps needed to isolate the molecule of interest from the biological machinery that makes it.

Chemical-based synthesis has another disadvantage. The process of manufacturing uses toxic chemicals that need to be dealt with appropriately and by waste management experts. Apart from administrative headaches, these chemicals are also not eco-friendly. So, even though they may be off your site, they are still polluting somewhere else. This has prompted biotech entrepreneurs to look for more innovative ways to synthesize DNA without having to deal with toxic chemicals but also speed up custom DNA production. 

GO Prime with only $1.49 now

LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
EVENT
Scroll to Top